Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer’s disease pathophysiology
Stephen Schauer, Balazs Toth, Julie Lee, Lee A. Honigberg, Vidya Ramakrishnan, Jenny Jiang, Gwendlyn Kollmorgen, Anna Bayfield, Norbert Wild, Jennifer Hoffman, Ryan Ceniceros, Michael Dolton, Sandra Sanabria Bohorquez, Casper C. Hoogenraad, Kristin R. Wildsmith, Edmond Teng, Cecilia Monteiro, Veronica Anania, Felix L. Yeh
medRxiv 2024.04.18.24306056; doi: https://doi.org/10.1101/2024.04.18.24306056